CoChat

Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing

Open access

The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.

Abstract

UNLABELLED: Precise delineation of the specific genes and pathways altered with aging and estrogen (E) therapy may lead to new skeletal biomarkers and the development of novel bone therapeutics. Previous human bone studies, however, have been limited by only examining pre-specified genes and pathways. High-throughput RNA sequencing (RNAseq), on the other hand, offers an unbiased approach to examine the entire transcriptome. Here we present an RNAseq analysis of human bone samples, obtained from iliac crest needle biopsies, to yield the first in vivo interrogation of all genes and pathways that may be altered in bone with aging and E therapy in humans. 58 healthy women were studied, including 19 young women (mean age ± SD, 30.3 ± 5.4 years), 19 old women (73.1 ± 6.6 years), and 20 old women treated with 3 weeks of E therapy (70.5 ± 5.2 years). Using generally accepted criteria (false discovery rate [q] < 0.10), aging altered a total of 678 genes and 12 pathways, including a subset known to regulate bone metabolism (e.g., Notch). Interestingly, the LEF1 transcription factor, which is a classical downstream target of the Wnt/β-catenin signaling pathway, was significantly downregulated in the bones from the old versus young women; consistent with this, LEF1 binding sites were significantly enriched in the promoter regions of the differentially expressed genes in the old versus young women, suggesting that aging was associated with alterations in Wnt signaling in bone. Further, of the 21 unique genes altered in bone by E therapy, the expression of INHBB (encoding for the inhibin, beta B polypeptide), which decreased with aging (by 0.6-fold), was restored to young adult levels in response to E therapy. In conclusion, our data demonstrate that aging alters a substantial portion of the skeletal transcriptome, whereas E therapy appears to have significant, albeit less wide-ranging effects. These data provide a valuable resource for the potential identification of novel biomarkers associated with age-related bone loss and also highlight potential pathways that could be targeted to treat osteoporosis. TRIAL REGISTRATION: ClinicalTrials.gov NCT02349113.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0138347

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Flow diagram for enrollment and allocation of the subjects in the E arm of the study.
Fig 1 Flow diagram for enrollment and allocation of the subjects in the E arm of the study.CC BY · PubMed Central
Fig 2 (A) Notch pathway and (B) Wnt/β-catenin pathway genes are altered with aging in human bone biopsies. Genes in the Notch pathway and Wnt/β-catenin pathway are significantly altered in old relative to young women revealed by RNAseq based on pathway analysis using the Ingenuity Pathway Analysis software (see Statistical analyses). Values are presented as median fold changes (95% CIs) for old relative to young subjects. † p < 0.01; ‡ p < 0.001.
Fig 2 (A) Notch pathway and (B) Wnt/β-catenin pathway genes are altered with aging in human bone biopsies. Genes in the Notch pathway and Wnt/β-catenin pathway are significantly altered in old relative to young women revealed by RNAseq based on pathway analysis using the Ingenuity Pathway Analysis software (see Statistical analyses). Values are presented as median fold changes (95% CIs) for old relative to young subjects. † p < 0.01; ‡ p < 0.001.CC BY · PubMed Central
Fig 3 Networks derived from age-related differentially expressed genes (DEGs) in bone. (A) Top 10 scoring networks and associated network functions derived from the 678 DEGs altered (median count ≥ 10, q < 0.10) in the young versus old dataset determined using the Ingenuity Pathway Analysis software (see Statistical Analysis). (B) Network of cell morphology, hematological system development and function, and protein synthesis (score = 33); key molecules implicated in bone metabolism include LEF1 and CDKN1A (p21). (C) Network of cardiovascular system development and function, cellular development, and organismal development (score = 31); key molecules implicated in bone metabolism include Notch signaling components (NOTCH3, NOTCH4, HEY1, JAG2, and DLL4) and SEMA3A. Green indicates downregulated genes, and red indicates upregulated genes.
Fig 3 Networks derived from age-related differentially expressed genes (DEGs) in bone. (A) Top 10 scoring networks and associated network functions derived from the 678 DEGs altered (median count ≥ 10, q < 0.10) in the young versus old dataset determined using the Ingenuity Pathway Analysis software (see Statistical Analysis). (B) Network of cell morphology, hematological system development and function, and protein synthesis (score = 33); key molecules implicated in bone metabolism include LEF1 and CDKN1A (p21). (C) Network of cardiovascular system development and function, cellular development, and organismal development (score = 31); key molecules implicated in bone metabolism include Notch signaling components (NOTCH3, NOTCH4, HEY1, JAG2, and DLL4) and SEMA3A. Green indicates downregulated genes, and red indicates upregulated genes.CC BY · PubMed Central
Fig 4 Effects of age and estrogen (E) on serum sclerostin levels. Serum sclerostin levels in the young versus old subjects (A) and in the old versus E-treated subjects (B) by the Biomedica and Meso Scale Discovery (MSD) assays. Data are mean ± SEM; note the difference in scales for the two sclerostin assays. *p < 0.05; † p < 0.01.
Fig 4 Effects of age and estrogen (E) on serum sclerostin levels. Serum sclerostin levels in the young versus old subjects (A) and in the old versus E-treated subjects (B) by the Biomedica and Meso Scale Discovery (MSD) assays. Data are mean ± SEM; note the difference in scales for the two sclerostin assays. *p < 0.05; † p < 0.01.CC BY · PubMed Central
Fig 5 Effects of age and estrogen (E) on gene expression of INHBA and INHBB. Bone INHBB and INHBA gene expression levels by RNAseq in the old relative to young women (A) and in the E-treated relative to untreated old women (B). Data are shown as median fold changes (95% CIs). † p < 0.01; ‡ p < 0.001.
Fig 5 Effects of age and estrogen (E) on gene expression of INHBA and INHBB. Bone INHBB and INHBA gene expression levels by RNAseq in the old relative to young women (A) and in the E-treated relative to untreated old women (B). Data are shown as median fold changes (95% CIs). † p < 0.01; ‡ p < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 67 references

Cited by

See all 75

Metadata

Authors
Farr, J. N., Roforth, M. M., Fujita, K., Nicks, K. M., Cunningham, J. M., Atkinson, E. J., Therneau, T. M., McCready, L. K., Peterson, J. M., Drake, M. T., Monroe, D. G., & Khosla, S.
Affiliations
Mayo Clinic (US)
Corresponding author
Khosla, Sundeep
Venue
PLOS ONE
Published
2015-09-24
Volume
10
Issue
9
Pages
e0138347
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2256201617
Cited by
75
References
68
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 10 · 2020: 12 · 2019: 9 · 2018: 10 · 2017: 6 · 2016: 4
FWCI
6.85
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institutes of Health (UL1TR000135, AG004875, TR000135)
  • Center for Clinical and Translational Science, Mayo Clinic (UL1‐TR000135, TR000135)
  • National Institute on Aging (P01AG004875, AG004875)
  • NIH Clinical Center
  • National Center for Advancing Translational Sciences (TR000135)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
bone aging, estrogen therapy, gene expression, Wnt/β-catenin signaling, LEF1, Notch signaling, INHBB, inhibin beta B, osteoporosis, age-related bone loss, bone turnover markers, iliac crest bone, women
MeSH terms
Adult, Age Factors, Aged, Aged, 80 and over, Biopsy, Bone and Bones, Estrogens, Female, Gene Expression Regulation, Genetic Markers, Humans, Male, Regulatory Sequences, Nucleic Acid, Signal Transduction, Biomarkers, Sequence Analysis, RNA, Bone Morphogenetic Proteins, Gene Expression Profiling, Adaptor Proteins, Signal Transducing, Gene Regulatory Networks, Young Adult, High-Throughput Nucleotide Sequencing, Nucleotide Motifs, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing. https://app.cochat.ai/papers/10.1371/journal.pone.0138347
The paper
Farr, J. N., Roforth, M. M., Fujita, K., Nicks, K. M., Cunningham, J. M., Atkinson, E. J., Therneau, T. M., McCready, L. K., Peterson, J. M., Drake, M. T., Monroe, D. G., & Khosla, S. (2015). Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing. PLOS ONE. https://doi.org/10.1371/journal.pone.0138347

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.